SBC Medical Group (NASDAQ:SBC - Get Free Report) posted its quarterly earnings results on Friday. The company reported $0.18 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.01, Zacks reports. The business had revenue of $57.90 million for the quarter, compared to analyst estimates of $56.34 million.
SBC Medical Group Trading Down 1.5 %
Shares of SBC traded down $0.05 during mid-day trading on Wednesday, reaching $3.00. The company had a trading volume of 7,288 shares, compared to its average volume of 58,643. The company has a current ratio of 2.79, a quick ratio of 2.76 and a debt-to-equity ratio of 0.06. The business's 50 day moving average price is $4.34. SBC Medical Group has a 1-year low of $2.62 and a 1-year high of $12.50.
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Further Reading
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
